Status & Overview EIT Health CESAER MeeBng, 8 October 2015 EIT Health is supported by the EIT, a body of the European Union
EIT Health is a leading academic- industrial partnership to commercialize innova9ons 2015: successful setup in line with the winning bid and the mission 2016: first project porwolio indicabng future themabc alignment 2018: gradual enlargement along strategic fit Picture: hlp://wall.alphacoders.com/big.php?i=313893
The Mission: EIT Health accelerates entrepreneurship and innova9on in healthy living and ac9ve ageing, providing Europe s top talents with new opportuni9es and resources to the benefit of all ci9zens. Crea9ng 165 start- ups and launching another 160 new services and products Having 1 million students taking part in educa9onal online programmes per year Incubate approximately 340 new business ideas 2016-18
Focus areas support cibzens desire for an acbve and self- determined life, even at old age Promote Healthy Living Self- management of health Support Active Ageing Workplace interven9ons Improve Healthcare Improving healthcare systems Lifestyle interven9on Overcoming func9onal loss Trea9ng and managing chronic diseases Mo9vate ac9ve personal lifestyles Ageing with a Healthy Brain Personalised Oncology and Integrated Cancer Care Metabolic Health Mobility and independence throughout Life Sustainable Con9nuum of Care to Support Ac9ve Living in Europe Business Objectives Example s
EIT Health partnership An alliance of 130+ leading organizabons (Pharma, MedTech, Payers, Research InsBtuBons and UniversiBes) and one of the largest healthcare inibabves world- wide 5
European reach 6 co- locabon centres in UK/Ireland (London), Scandinavia (Stockholm), Belgium/Netherlands (RoLerdam), Germany (Mannheim/Heidelberg), France (Paris), Spain (Barcelona) 6 InnoStars regions: CroaBa, Hungary, Poland, Portugal, Slovenia, Wales; implemenbng EU widening strategy Co- loca9on centres InnoStars regions Interna9onal HQs
Milestones achieved Winning bid at EIT Dec 2014 EIT Health e.v. registered Aug 18 CEO appointed Sept 1 Partner Assembly approved Business Plan (BP) and Strategic Agenda (SA) Sept 19 Submission of BP and SA to EIT Sept 30 7
Key achievements in 2015 Formally established the KIC LE on Bme Built a strong porwolio of acbvibes Selected 22 InnovaBon s Launched branding and communica- Bon acbvibes On- boarding of management team on- going Set- up of all CLCs and InnoStars to be concluded by end of 2015 Prepared the launch of the Accelerator Developed the Campus porwolio following the STELLAR approach Carried out first acbvibes (Summer School) Developed relabonships with the EC and the EIT 8
2015: state- of- the- art selec9on process led to high quality project por^olio I. Call for EIT projects II. Select project III. Apply decision framework per project IV. Optimize project portfolio V. Approve portfolio Approach Output Health challenges Strategic Goal Strategic Goal Eval criteria Eval criteria Eval criteria Eval criteria Eval criteria Evalua9on criteria Long list of eligible Proposed projects (Idea & Design) projects A-Level s B-Level s C-Level s Mul9- dimensional decision framework for project selec9on Assessment & ranking of projects + ini9al selec9on s @ hearing A-Level B-Level û û portfolio Adjus9ng, combining and balancing of projects in por^olio Pre- selec9on of project por^olio Decision and communica9on of project selec9on June 21 July 1 July 31 Aug. 25 Sept. 18 23th Eligibility meeting û 24th 27/28th 21st 25th External reviews Consensus meeting Hearings Portfolio meeting % Risk Strategic Challenges 1 2 3 NPV Max Min 9
s integrate Knowledge Triangle Example project: Rare cancer virtual pathology service EsBmated KPIs for year 1* and 2-3 12 InnovaBon fellowships 120 Trained Professionals 10 Industry- Academy Exchange 1 Rare Cancer MOOC** 20 Open Course modules (MOOCs) 100 Ideas 3 Start ups 5 Service Piloted* 10 launched 5 Product (diagnosbc) Launched 20 Knowledge Transfer 6 Employee* 10 M Capital ALracted EIT Rare Cancer KPIs 3 EIT Members* (Industry, Academy, Research) 3 CLC (1 InnoStars)* 200K KAVA* 7.5M KCA* 1 Website* 3 Social Media Impact* 4 Events (250 pe event)* 4 Press Coverage (link to event) 20,000 Media Audience* Note: The project is an example, funding is under approval EORTC is the European Organisation for Research and Treatment of Cancer
Gradual enlargement along strategic fit formal commitment Campus Accelerator s Individuals, Young talents, Health professionals, Entrepreneurs should try to join programs such as Summer School, Fellowship, etc. Business Plan CompeBBons in each CLC/Innostars, Business CreaBon Services such as GoGlobal and Entrep.Lab for companies in expansion phase ParBcipaBng in InnovaBon s as project partners, Offering complementary capabilibes such as test beds Partnership after 2018 Strategic fit Proven contribution Recommending CLC Interested? Contact your acbve colleagues if your insbtubon is a partner Visit CLC meebngs, EIT Health conferences, respond to open calls
EIT Health Pillars: Cross- linkages PROJECTS, CAMPUS and ACCELERATOR Outcome 2016 >150,000 parbcipants in EIT Health online courses Launch 19 new products and services Incubate 70 new business ideas
From Triangle to Pyramid: Cross- linkages A co- creabon workshop at an InnovaBon Day executed within the CAMPUS Area may bring a mulb- disciplinary team together around a concrete need A large company can launch a collaborabve InnovaBon by Design project to develop the ideas, and bring a suitable product or service to market. The CLCs support the organizabon of co- creabon workshops to involve end- users/pabents in the project acbvibes. Coaches from the ACCELERATOR will be embedded in the project to support the team in building the business case and crossing market access barriers. The ACCELERATOR will help the project to test the product/ service in living labs and test beds across Europe. The disrupbve nature of the innovabon may inspire the CAMPUS in EIT Health to engage and develop short courses to ensure correct and efficient use of the newly developed tools. 13
EIT Health Nu går (startar) tåget.. Thank you